AlgoraeOS Version 2 AI Platform Launched

• AlgoraeOS v2 launched: major upgrade to Algorae’s AI drug discovery platform. • Benchmark leadership: outperformed representative state-of-the-art models, including Google DeepMind’s TxGemma-27B-Predict and Tx-LLM (M) on NCI-ALMANAC (70/10/20 split). • Trained at scale: over 5.5M unique inhibition records; full dose-response surfaces; Bliss/Loewe/HSA/ZIP + dose-specific inhibition. • Confidence-